Orexigen Therapeutics Newswire

Orexigen Therapeutics Newswire

Comprehensive Real-Time News Feed for Orexigen Therapeutics.

Results 1 - 20 of 220 in Orexigen Therapeutics

  1. Orexigen Therapeutics Inc. (OREX) Trading Down 1.4%Read the original story w/Photo

    Yesterday | Daily Political

    Shares of Orexigen Therapeutics Inc. were down 1.4% during trading on Tuesday . The company traded as low as $4.29 and last traded at $4.35, with a volume of 50,571 shares traded.

    Comment?

  2. Orexigen Therapeutics Inc. (NASDAQ:OREX) Receives Consensus...Read the original story w/Photo

    Friday Aug 19 | AmericanBankingNews.com

    Orexigen Therapeutics Inc. has been assigned an average recommendation of "Hold" from the nine brokerages that are currently covering the firm. One investment analyst has rated the stock with a sell recommendation and eight have assigned a hold recommendation to the company.

    Comment?

  3. Orexigen Therapeutics Inc. (OREX) Shares Up 6.2%Read the original story w/Photo

    Wednesday Aug 17 | Daily Political

    Orexigen Therapeutics Inc. shares shot up 6.2% during mid-day trading on Monday . The stock traded as high as $4.52 and last traded at $4.44, with a volume of 110,780 shares.

    Comment?

  4. Orexigen Therapeutics Inc. (OREX) Trading 6.2% HigherRead the original story w/Photo

    Monday Aug 15 | Daily Political

    Orexigen Therapeutics Inc. 's share price traded up 6.2% during trading on Monday . The company traded as high as $4.52 and last traded at $4.44, with a volume of 110,780 shares traded.

    Comment?

  5. Zacks Investment Research Lowers Orexigen Therapeutics Inc. (OREX) to HoldRead the original story w/Photo

    Monday Aug 15 | Daily Political

    ... regions. We are also encouraged by the favorable Markman ruling in the patent infringement case." Orexigen Therapeutics ( NASDAQ:OREX ) opened at 4.18 on Tuesday. The company's market cap is $60.97 million. The company's 50-day moving average is ...

    Comment?

  6. Orexigen Therapeutics Inc. (OREX) Stock Rating Upgraded by Zacks Investment ResearchRead the original story w/Photo

    Wednesday Aug 10 | Daily Political

    ... as well. Orexigen is currently in discussions with potential partners for additional regions." Orexigen Therapeutics ( NASDAQ:OREX ) traded down 2.59% on Monday, reaching $4.14. 309,547 shares of the company's stock were exchanged. The company's ...

    Comment?

  7. Orexigen Reports Loss - Company Tries To Encourage Investors Despite Slow GrowthRead the original story w/Photo

    Monday Aug 8 | Seeking Alpha

    Orexigen reported its Q2 2016 financial results on August 4th. As was expected, the company had a loss.

    Comment?

  8. Orexigen Therapeutics Inc. (OREX) Trading Up 7.3%Read the original story w/Photo

    Saturday Aug 6 | Daily Political

    Orexigen Therapeutics Inc. 's share price was up 7.3% on Thursday . The stock traded as high as $3.57 and last traded at $3.53, with a volume of 173,421 shares trading hands.

    Comment?

  9. Orexigen Therapeutics Inc. (OREX) Issues Earnings ResultsRead the original story w/Photo

    Friday Aug 5 | Daily Political

    Orexigen Therapeutics Inc. released its quarterly earnings results on Thursday. The biopharmaceutical company reported EPS for the quarter, missing analysts' consensus estimates of by $0.26.

    Comment?

  10. Orexigen Therapeutics Inc. (OREX) Stock Price Up 7.3%Read the original story w/Photo

    Thursday Aug 4 | Daily Political

    Orexigen Therapeutics Inc. shares rose 7.3% on Thursday . The stock traded as high as $3.57 and last traded at $3.53, with a volume of 173,421 shares.

    Comment?

  11. Orexigen Therapeutics Inc. (OREX) Sets New 52-Week Low at $3.18Read the original story w/Photo

    Thursday Aug 4 | Daily Political

    Shares of Orexigen Therapeutics Inc. hit a new 52-week low during mid-day trading on Tuesday . The stock traded as low as $3.18 and last traded at $3.19, with a volume of 105,997 shares trading hands.

    Comment?

  12. Orexigen Therapeutics Inc. (OREX) to Release Earnings on ThursdayRead the original story w/Photo

    Wednesday Aug 3 | AmericanBankingNews.com

    Orexigen Therapeutics Inc. is scheduled to announce its Q216 earnings results on Thursday, August 4th. Analysts expect the company to announce earnings of per share and revenue of $6.88 million for the quarter.

    Comment?

  13. Orexigen Therapeutics Inc. (OREX) Hits New 1-Year Low at $3.18Read the original story w/Photo

    Tuesday Aug 2 | Daily Political

    Shares of Orexigen Therapeutics Inc. hit a new 52-week low during trading on Tuesday . The company traded as low as $3.18 and last traded at $3.19, with a volume of 105,997 shares changing hands.

    Comment?

  14. Orexigen Therapeutics Inc. (OREX) Scheduled to Post Quarterly Earnings on ThursdayRead the original story w/Photo

    Tuesday Aug 2 | Daily Political

    Orexigen Therapeutics Inc. is set to announce its Q216 earnings results on Thursday, August 4th. Analysts expect the company to announce earnings of per share and revenue of $6.88 million for the quarter.

    Comment?

  15. Orexigen Announces Commercialization And Distributorship Agreement...Read the original story

    Sunday Jul 31 | BioSpace

    Orexigen Announces Commercialization And Distributorship Agreement With Laboratorios Farmace Uticos Rovi, S.A. For Mysimba In Spain /PRNewswire/ -- Orexigen Therapeutics, Inc. today announced that wholly owned subsidiary Orexigen Therapeutics Ireland Ltd. and Laboratorios Farmaceuticos Rovi, S.A. have executed a commercialization and distributorship agreement for Mysimba in Spain. Mysimba is approved by the European Medicines Agency for the management of weight in adult patients with an initial Body Mass Index of 30 kg/m2 , or 27 kg/m2 to 5 percent) seen in patients taking Mysimba / Contrave included nausea, constipation, headache, vomiting, dizziness, insomnia, dry mouth, and diarrhea.

    Comment?

  16. Orexigen Therapeutics Inc. (OREX) Trading Up 7%Read the original story w/Photo

    Thursday Jul 28 | Daily Political

    Orexigen Therapeutics Inc. was up 7% on Wednesday . The company traded as high as $3.50 and last traded at $3.50, with a volume of 205,438 shares changing hands.

    Comment?

  17. Orexigen Therapeutics Inc. (OREX) Sets New 52-Week Low at $3.42Read the original story w/Photo

    Wednesday Jul 27 | Daily Political

    Shares of Orexigen Therapeutics Inc. hit a new 52-week low during trading on Monday . The stock traded as low as $3.42 and last traded at $3.42, with a volume of 150,675 shares trading hands.

    Comment?

  18. Orexigen Therapeutics Inc. (OREX) Shares Down 3.5%Read the original story w/Photo

    Tuesday Jul 26 | Daily Political

    Shares of Orexigen Therapeutics Inc. were down 3.5% during trading on Tuesday . The company traded as low as $3.26 and last traded at $3.31, with a volume of 95,136 shares traded.

    Comment?

  19. Orexigen Therapeutics Inc. (OREX) Sets New 1-Year Low at $3.42Read the original story w/Photo

    Monday Jul 25 | Daily Political

    Orexigen Therapeutics Inc. shares hit a new 52-week low during trading on Monday . The company traded as low as $3.42 and last traded at $3.42, with a volume of 150,675 shares changing hands.

    Comment?

  20. Vivus Announces Positive Ruling In Qsymia Litigation - Will It Matter?Read the original story w/Photo

    Jul 22, 2016 | Seeking Alpha

    Vivus announced today that the company won a small battle with regard to the definition of certain terms within its patents. The court ruling, known as a Markman ruling, defines the definitions of terms that are viewed as important or even critical in the case regarding patent litigation.

    Comment?